Cargando…
Association Between Dexamethasone Treatment After Hospital Discharge for Patients With COVID-19 Infection and Rates of Hospital Readmission and Mortality
IMPORTANCE: Current guidelines recommend use of dexamethasone, 6 mg/d, up to 10 days or until discharge for patients hospitalized with COVID-19. Whether patients who received less than 10 days of corticosteroids during hospitalization for COVID-19 benefit from continuing treatment at discharge has n...
Autores principales: | Huang, Cheng-Wei, Yu, Albert S., Song, Hubert, Park, Joon S., Wu, Stefanie S., Khang, Vang Kou, Subject, Christopher C., Shen, Ernest |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Medical Association
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8905383/ https://www.ncbi.nlm.nih.gov/pubmed/35258575 http://dx.doi.org/10.1001/jamanetworkopen.2022.1455 |
Ejemplares similares
-
Disease-Specific Factors Associated with Readmissions or Mortality After Hospital Discharge in COVID-19 Patients: a Retrospective Cohort Study
por: Huang, Cheng-Wei, et al.
Publicado: (2022) -
Association of Hospital Discharge Against Medical Advice With Readmission and In-Hospital Mortality
por: Tan, Sally Y., et al.
Publicado: (2020) -
Interventions to Improve Communication at Hospital Discharge and Rates of Readmission: A Systematic Review and Meta-analysis
por: Becker, Christoph, et al.
Publicado: (2021) -
Time to hospital discharge and subsequent hospital readmission and mortality rates in icu survivors
por: Campbell, R, et al.
Publicado: (2015) -
Mortality and Readmission Rates Among Patients With COVID-19 After Discharge From Acute Care Setting With Supplemental Oxygen
por: Banerjee, Josh, et al.
Publicado: (2021)